-+ 0.00%
-+ 0.00%
-+ 0.00%

BeyondSpring Reports Plinabulin Plus Docetaxel Boosts Survival in Asian EGFR Wild-Type NSCLC Phase 3 Trial

Reuters·12/12/2025 12:00:56

Please log in to view news